Chairman
Johnson & Johnson (JNJ)Equibles does not estimate personal net worth.
Get an email with a short summary when Johnson & Johnson publishes a filing, an earnings call transcript or a press release.
Get JNJ alertsHani Abulhalka is recorded as Chairman at Johnson & Johnson (JNJ). Hani Abulhalka has spoken on 1 investor event across 1 company, most recently for Johnson & Johnson on March 10, 2026. Johnson & Johnson is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Johnson & Johnson includes J. Wolk (CFO), D. E. Pinto (Board Member), Daniel Pinto (Board Member) and 7 others.
“Matt, we're not going to, as you would expect, we're not going to share specifics around our commercial launch. there'll be more to share as we come, but I'll say a few things.”
Drug Manufacturers - General · Healthcare
Chairman
